Pfizer's Maddaluna on Integrating Wyeth's Manufacturing Organization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pfizer’s Maddaluna on Integrating Wyeth’s Manufacturing Organization



Anthony J. Maddaluna
Senior Vice President, PGM Strategy and Supply Network Transformation
Pfizer, Inc.

Add this Podcast feed to your media player



What is the future of Pfizer’s global manufacturing network following the Wyeth acquisition? In this interview, Tony Maddaluna, senior vice-president of Strategy and Supply Network Transformation at Pfizer Global Manufacturing (PGM), outlines the company’s plans for manufacturing integration.

More Podcasts>>

Related Topic

Big Pharma Tightens Its Global Manufacturing Belt (August 2009)


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search

Click here